46 Participants NeededMy employer runs this trial

Cerebral Physiology for Neonatal Opioid Withdrawal Syndrome

(NIRS for NOWS Trial)

HR
AT
Overseen ByAnna Thomas, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.

Who Is on the Research Team?

AT

Anna Thomas, MD

Principal Investigator

Indiana University

SF

Silvina Ferradal, PhD

Principal Investigator

Indiana University

Are You a Good Fit for This Trial?

This trial is for newborns born at or after 36 weeks, weighing over 2 kg, whose mothers are at least 19 years old and used opioids during pregnancy (either prescribed or illicit).

Inclusion Criteria

I was born at or after 36 weeks of pregnancy.
I am pregnant and currently use or am being treated for opioid use.
I was exposed to opioids before I was born.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • FD-NIRS and DCS

Trial Overview

Researchers are using a new device to measure brain blood flow and oxygen levels in babies exposed to opioids before birth, compared to those who were not exposed.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Prenatal opioid exposure (POE)Experimental Treatment1 Intervention
Group II: Pharmacologic TreatmentExperimental Treatment1 Intervention
Group III: Healthy controlExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

Indiana Clinical and Translational Sciences Institute

Collaborator

Trials
20
Recruited
4,400+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+